Bovine parainfluenza virus type 3 (BPIV3) is an important pathogen associated with bovine respiratory disease complex (BRDC). We have generated a recombinant BPIV3 expressing enhanced green fluorescent protein (rBPIV3-EGFP) based on the BN-1 strain isolated in Japan. After intranasal infection of hamsters with rBPIV3-EGFP, EGFP fluorescence was detected in the upper respiratory tract including the nasal turbinates, pharynx, larynx, and trachea. In the nasal turbinates, rBPIV3-EGFP attained high titers (> 10 6 TCID50/g of tissue) 2 to 4 days after infection. Ciliated epithelial cells in the nasal turbinates and trachea were infected with rBPIV3-EGFP.
Infection of the Upper Respiratory Tract of Hamsters by the Bovine

INTRODUCTION
Bovine parainfluenza virus type 3 (BPIV3), a member of the genus Respirovirus in the family Paramyxoviridae, is an enveloped virus with a non-segmented negative-sense RNA genome (Karron and Collins, 2013) . BPIV3 is one of the most important viruses associated with bovine respiratory disease complex (BRDC), commonly referred as "Shipping fever", in cattle (Autio et al., 2007; Snowder et al., 2007) . The BPIV3 genome encodes six structural proteins: the nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), hemagglutinin-neuraminidase (HN), and large (L) proteins. The P gene also encodes three accessory proteins, the C, V and D
proteins. The C protein is translated from an alternative translation initiation site resulting in a different reading frame, and the V and D proteins are translated from edited mRNAs. Two envelope glycoproteins, the HN and F proteins, mediate receptor binding and membrane fusion, respectively. Therefore, the HN protein is primarily responsible for determining the tropism of BPIV3 (Karron and Collins, 2013) .
The HN protein recognizes sialic acid-containing cellular glycoconjugates.
Although the fine structure of sialic-acid residues that bind the HN protein of BPIV3
have not yet been reported, those that bind to the HN protein of the closely related human parainfluenza type 3 virus (HPIV3) have been reported (Amonsen et al., 2007; Fukushima et al, 2014; Suzuki et al., 2001; Zhang et al., 2005) . In a cell-based assay using an in vitro model of human airway epithelium and neuraminidases specific for α2-6-linked or α2-3-/α2-8-linked sialic acid residues, HPIV3 was reported to utilize α2-6-linked sialic acid residues for initiating infection (Zhang et al., 2005) . On the other hand, in a non-cell-based assay using purified gangliosides, HPIV3 was reported to bind to both α2-3-and α2-6-linked sialic acid residues (Fukushima et al, 2014; Suzuki et al., 2001 ). In another non-cell-based assay using the glycan array of the Consortium for Functional Glycomics, HPIV3 was reported to bind α2-3-linked sialic acid residues (Amonsen et al., 2007) . In addition, another study reported that HPIV3 also utilized heparin sulfate moieties on the cell surface (Bose and Banerjee, 2002) .
Thus, the receptor specificity of HPIV3 and BPIV3 is still controversial.
For the pathogenesis of BPIV3, only limited studies of its pathogenesis in calves have been reported (Tsai and Thomson, 1975; Van der Maaten, 1969b) . This virus also infects rhesus monkeys, chimpanzees, and humans, although replication is limited and restricted to the respiratory tract in those hosts (Karron and Collins, 2013) . Hamsters are often used as small models for studying BPIV3 tropism (Van der Maaten, 1969a) and for evaluating the efficacy of recombinant BPIV3 vaccines (Haller et al., 2000; Schmidt et al., 2001 To make recombinant BPIV3 expressing the EGFP, we introduced the EGFP gene between the N and P genes of the p(+)BPIV3, resulting in the p(+)BPIV3-EGFP. Then, infectious virus (rBPIV3-EGFP) was recovered from the p(+)BPIV3-EGFP. Repeated attempts to recover recombinant virus having the EGFP gene between the leader sequence and the N gene were not successful (data not shown).
In vitro characterization of rBPIV3 and rBPIV3-EGFP.
First, we compared the growth of BPIV3, rBPIV3 and rBPIV3-EGFP in MDBK cells (Fig. 3A) . All virus strains showed similar replication kinetics and attained peak titers of 10 10 50% tissue culture infective dose (TCID50)/ml, suggesting that rBPIV3 retained the phenotype of BPIV3 and that the EGFP gene had no obvious detrimental effect on the growth of rBPIV3-EGFP. rBPIV3-EGFP replicated and expressed EGFP in several other cell lines including CV-1, Vero, HeLa, HEp-2 and 293 cells, but did not induce syncytium formation (Fig. 3B ).
Macroscopic detection of EGFP fluorescence in organs and tissues.
To examine the systemic infection of BPIV3 in hamsters, we infected hamsters with rBPIV3-EGFP. Hamsters were infected intranasally with 1 × 10 6 TCID50 of rBPIV3-EGFP in a 100 µl volume. No clinical signs were observed during the course of the experiment. Upon necropsy at 2 days post-infection, EGFP fluorescence was detected in the nasal turbinates and weakly in the trachea of all hamsters. On day 4, strong EGFP fluorescence was detected in the entire region of the nasal turbinates, pharynx, larynx, and trachea of all hamsters (Fig. 4) . There was no expression in other tissues and organs. EGFP-expressing cells were restricted in the lumen of the trachea (Fig. 4) . Unexpectedly, EGFP fluorescence was not detected in any sections of the lungs of all hamsters. By day 6, the intensity of the EGFP fluorescence had rapidly weakened in those tissues and was no longer detectable by day 8.
Growth of rBPIV3-EGFP in nasal turbinates and trachea of hamsters.
We then examined the growth of rBPIV3-EGFP in the nasal turbinates and trachea of infected hamsters. In the nasal turbinates, rBPIV3-EGFP attained very high titers (> by 1 log10 was detected by day 6, and titers rapidly dropped by 3 log10 by day 8 (Table   1 ). In the trachea, rBPIV3-EGFP attained high titers (10 4.5 TCID50/g of tissue) by day 2 and increased to very high titers (10 5.7 TCID50/g of tissue) by day 4. Titers then decreased by 2 log10 by day 6 and were further reduced by 1 log10 by day 8, indicating that the infection was rapidly cleared within a few days.
We could not detect efficient virus growth in the lung (Table 1) , although previous reports indicated efficient virus growth in both the nasal turbinates and lungs (Haller et al., 2000; Schmidt et al., 2001) . To examine whether the EGFP gene introduced in rBPIV3-EGFP attenuated virus growth in lungs, we infected hamsters with recombinant virus without the EGFP (rBPIV3). Again, rBPIV3 replicated efficiently in both the nasal turbinates (10 6.2 TCID50/g of tissue) and trachea (10 5.0 TCID50/g of tissue) but less efficiently in the lungs (10 3.7 TCID50/g of tissue) ( Table 2 ), suggesting that the EGFP gene did not attenuate virus growth in the lungs of hamsters.
To examine whether lower numbers of virus can establish infection in hamsters, we infected hamsters with lower doses (10 5 or 10 4 TCID50 of virus per animal) of rBPIV3-EGFP. When hamsters were infected with 10 5 or 10 4 TCID50 of rBPIV3-EGFP, 10 6.1 or 10 5.5 TCID50/g of tissue of virus were recovered from the trachea of hamsters, respectively ( Table 2 ), indicating that lower doses of virus could still establish the infection in hamsters.
Ciliated epithelial cells were preferentially infected with rBPIV3-EGFP.
To identify the infected cells in the nasal turbinates and tracheas, we observed frozen section of these tissues under a fluorescent microscope. Ciliated cells stained with cilia-specific antibody (β-tubulin IV) were found to be exclusively infected by rBPIV3-EGFP in both the nasal turbinates and trachea ( Fig. 5A and B). Infection did not spread to underlying basal cells and did not induce syncytium formation between infected and uninfected cells.
Mucosal epithelial cell shedding and lymphocytic infiltration.
To examine the pathogenesis of BPIV3 in hamsters, we performed a histopathological analysis of fixed specimens of the nasal turbinates, trachea, and bronchi. On day 6, sloughed ciliated epithelial cells, cell debris, and red blood cells were observed in the lumen of the bronchi (Fig. 6 ). Diffuse expansions of the alveolar interstitia due to mononuclear cell infiltrates were also observed on day 6, but not observed in on days 2 or 4. Mucosal epithelial cells shed by day 6 post-infection left non-ciliated cells in the lumen of bronchi (Fig. 6 ).
DISCUSSION AND CONCLUSIONS
In this study, we have analyzed the in vivo tropism of BPIV3 in hamsters using EGFP-expressing recombinant BPIV3 based on the BN-1 strain. Previous studies indicated that BPIV3 replicates in the respiratory tracts of hamsters (Haller et al., 2000; Schmidt et al., 2001; Van der Maaten, 1969a) , but the systemic infection and the exact cell tropism of BPIV3 were not examined. We observed EGFP expression in the entire region of the nasal turbinates, pharynx, larynx, and trachea (Fig. 3) . In particular, we detected high titers of virus (> 10 6 TCID50/g of tissues) on days 2 and 4 post-infection in the nasal turbinates (Table 1) . These titers were equivalent or 10 times higher than those reported previously (Haller et al., 2000; Schmidt et al., 2001 ). Interestingly, rBPIV3-EGFP did not grow efficiently in the lungs of hamsters. BPIV3 strains derived from the Kansas/15626/84 strain have been reported to replicate to similar levels in the nasal turbinates and the lungs of hamsters (Haller et al., 2000; Schmidt et al., 2001) , while upper respiratory tract-specific growth of BPIV3 in hamster has been reported for the SF-4 strain ( Van der Maaten, 1969a) . Therefore, it is likely that the differences in virus growth in the lungs in our study and in previous studies (Haller et al., 2000; Schmidt et al., 2001 ) may be attributed to the strains used, although our data do not exclude the possibility that the EGFP gene introduced in rBPIV3-EGFP may have some detrimental effect on virus growth in the lungs. There are 1184 nucleotide (312 amino acid) differences between the BN-1 and Kansas/15626/84 strains, including a 24-nucleotide insertion in the non-coding region in the F gene of the BN-1 strain (Ohkura et al., 2013) . These nucleotide and/or amino acid differences may affect the growth of the BPIV3 in the lungs of hamsters. For virus isolation from the lungs, we routinely used small pieces of the exterior regions of the lobes, which were far from bronchi. We speculated that sloughed ciliated epithelial cells in the bronchi (Fig. 6) were not included in our specimens from the lungs.
We observed that luminal ciliated epithelial cells in the nasal turbinates and trachea were infected with rBPIV3-EGFP (Fig. 4) . This observation is consistent with a previous report in which HPIV3 specifically replicated in ciliated cells of in vitro reconstituted human airway epithelium (Zhang et al., 2005) . Cell-cell fusion between infected cells and infection of basal cells were not observed in the trachea of hamsters (Fig. 4) as previously described (Zhang et al., 2005) . We also observed a massive shedding of the ciliated cell layer in the bronchi (Fig. 6) . The F protein of BPIV3 BN-1 strain has the preferred furin motif (Arg-X-Arg/Lys-Arg) at the F1 and F2 cleavage site, and accordingly, rBPIV3-EGFP does not require trypsin for replication in cell culture (Fig. 3) . However, EGFP expression in tissues and organs other than the respiratory tracts was not observed in hamsters. It is likely that host immunity may restrict BPIV3 replication within the respiratory tract (Karron and Collins, 2013) .
In summary, we investigated the systemic infection and the exact cell tropism of BPIV3 in hamsters using EGFP-expressing BPIV3. Our results reveal how infection with BPIV3 spreads within the respiratory tract of living animals after intranasal inoculation. This model is useful for studying the pathogenicity of BPIV3 and BPIV3-associated BRDC. Further studies involving infection of calves, the natural host, with rBPIV3-EGFP will be needed to confirm the results obtained in this study.
MATERIALS AND METHODS
Cells and viruses.
Madin-Darby bovine kidney (MDBK), Vero, 293, and HeLa monolayer cell cultures were maintained in Dulbecco's modified essential medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and antibiotics. HEp-2 and CV-1 monolayer cell cultures were maintained in minimal essential medium (MEM) supplemented with 10% FBS and antibiotics. The BPIV3 BN-1 strain was isolated at the National Institute of Animal Health, Japan (Inaba et al., 1963; Ohkura et al., 2013) . The modified vaccinia virus Ankara (MVA-T7), which expresses the phage T7 RNA polymerase (Wyatt et al., 1995) , was grown in chicken embryonic fibroblasts.
Cloning of the N, P and L genes of BPIV3 into a pGEM-3 plasmid vector.
To construct the N-expressing plasmid, the open reading frame of the N gene was 
Construction of the full-length BPIV3 cDNA expressing EGFP.
To construct the full-length BPIV3 cDNA, three fragments were amplified from viral RNA by RT-PCR and assembled stepwise (Fig. 1) . First, the fragment covering the BPIV3 leader sequence to the XhoI site at nucleotide position 2154 was amplified by RT-PCR. Then a BssHII site and the T7 promoter sequence were added by PCR using synthetic primers, resulting in the frg(BssHII-T7-XhoI). Second, the fragment covering from the NheI (the StuI site at nucleotide position 7917 was changed to a NheI site) to the BPIV3 trailer sequence was amplified, and the genomic hepatitis delta virus ribozyme sequence and a NotI site were added by PCR using synthetic primers. A XhoI site was added just before the NheI site to join to the frg(BssHII-T7-XhoI), resulting in the frg(XhoI-Ribozyme-NotI). Third, the fragment covering from the XhoI site at nucleotide position 2154 to the NheI was amplified by RT-PCR, resulting in the frg(XhoI-NheI). All fragments were cloned into the pBluescriptII KS(+), whose multiple cloning site was replaced with a fragment containing BssHII and NotI sites, 
Rescue of infectious virus from p(+)BPIV3-EGFP plasmid.
HeLa cells in a 6-well plate (80% confluent) were infected with vaccinia virus MVA-T7 at a multiplicity of infection (MOI) 
Growth curves.
Monolayer cultures of MDBK cells in 24-well cluster plates were infected with rBPIV3 or rBPIV3-EGFP at an MOI of 0.01 and incubated at 37˚C. At various times, media were harvested and the infectious titer was determined by the TCID50 in MDBK cells.
Infection of hamsters with BPIV3-EGFP.
Five-week-old Syrian golden hamsters (four animals per group) were anesthetized with isoflurane and infected intranasally with 1 × 10 6 TCID50 of rBPIV3-EGFP in a 100 µl volume. Animals were maintained separately in isolator cages. From 2 up to 8 days post-infection, animals were euthanized and the nasal turbinates, trachea and lungs (approximately 50 mg) were harvested, homogenized, and stored at −80˚C. The viral titers in the tissues were determined by TCID50 assay in MDBK cells. All animal experiments were performed in compliance with the guidelines of University of Tsukuba.
Macroscopic detection of EGFP fluorescence.
EGFP fluorescence in the tissues and organs of hamsters was observed using a VB-G25 fluorescence microscope equipped with a VB-7000/7010 charge-coupled device (CCD) detection system (Keyence, Osaka, Japan) or a BZ-X700 fluorescence microscope (Keyence) equipped with a cooled CCD digital camera. Composite images with a large depth-of-field were created by extracting the pixel information from multiple Z-stack images.
Histopathological and immunohistochemical analyses.
Tissues from the nasal turbinates and trachea to bronchi were fixed in 10%
phosphate-buffered formalin. DAPI was used to identify nuclei. No cell-to-cell fusion was observed between rBPIV3-EGFP-infected cells. Non-ciliated cells (asterisk) induced by mucosal ciliated cell shedding. Bar = 100 µm. 
